Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v7-FR
Language French French
Date Updated 2018-10-05 2018-05-24
Drug Identification Number 02177889 02177889
Brand name APO-CLONAZEPAM - TAB 0.5MG APO-CLONAZEPAM - TAB 0.5MG
Common or Proper name CLONAZEPAM CLONAZEPAM
Company Name APOTEX INC APOTEX INC
Ingredients CLONAZEPAM CLONAZEPAM
Strength(s) .5MG .5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL 500 BTL
ATC code N03AE N03AE
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-10-02 2017-10-02
Actual start date 2017-09-29 2017-09-29
Estimated end date 2018-10-01 2018-10-01
Actual end date 2018-10-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments